FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/oncology-DCISNuclearGradeVS

Packagehl7.fhir.us.breastcancer
TypeValueSet
Idoncology-DCISNuclearGradeVS
FHIR VersionR3
Sourcehttp://hl7.org/fhir/us/breastcancer/http://hl7.org/fhir/us/breastcancer/2018Sep/ValueSet-oncology-DCISNuclearGradeVS.html
URLhttp://hl7.org/fhir/us/breastcancer/ValueSet/oncology-DCISNuclearGradeVS
Version0.2.0
Statusdraft
Date2018-08-17T00:00:00+10:00
NameDCISNuclearGradeVS
TitleBC DCISNuclearGradeVS ValueSet
Realmus
Authorityhl7
DescriptionThe nuclear grade describes how closely the nuclei of cancer cells look like the nuclei of normal breast cells. In general, the higher the nuclear grade, the more abnormal the nuclei are and the more aggressive the tumor cells tend to be. In breast cancer, nuclear grade is typically evaluated for ductal carcinoma in situ (DCIS) only.

Resources that use this resource

StructureDefinition
oncology-DCISNuclearGrade-modelBC DCISNuclearGrade Logical Model
oncology-DCISNuclearGradeBC DCISNuclearGrade Profile

Resources that this resource uses

CodeSystem
sctSNOMED CT (all versions)
sctSNOMED codes used in this IG
sctveri

Narrative

Note: links and images are rebased to the (stated) source

BC DCISNuclearGradeVS ValueSet

The nuclear grade describes how closely the nuclei of cancer cells look like the nuclei of normal breast cells. In general, the higher the nuclear grade, the more abnormal the nuclei are and the more aggressive the tumor cells tend to be. In breast cancer, nuclear grade is typically evaluated for ductal carcinoma in situ (DCIS) only.


Source

{
  "resourceType": "ValueSet",
  "id": "oncology-DCISNuclearGradeVS",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "url": "http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-DCISNuclearGradeVS",
  "identifier": [
    {
      "system": "http://hl7.org/fhir/us/breastcancer",
      "value": "oncology.DCISNuclearGradeVS"
    }
  ],
  "version": "0.2.0",
  "name": "DCISNuclearGradeVS",
  "title": "BC DCISNuclearGradeVS ValueSet",
  "status": "draft",
  "date": "2018-08-17T00:00:00+10:00",
  "publisher": "The HL7 Cancer Interoperability Group sponsored by Clinical Interoperability Council Work Group (CIC)",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://www.hl7.org/Special/committees/cic/index.cfm"
        }
      ]
    }
  ],
  "description": "The nuclear grade describes how closely the nuclei of cancer cells look like the nuclei of normal breast cells. In general, the higher the nuclear grade, the more abnormal the nuclei are and the more aggressive the tumor cells tend to be. In breast cancer, nuclear grade is typically evaluated for ductal carcinoma in situ (DCIS) only.",
  "compose": {
    "include": [
      {
        "system": "http://snomed.info/sct",
        "concept": [
          {
            "code": "369781009",
            "display": "Ductal carcinoma in situ nuclear pleomorphism, grade 1: monotonous nuclei, 1.5 - 2.0 red blood cells diameters, with finely dispersed chromatin and only occasional nucleoli (finding)"
          },
          {
            "code": "369782002",
            "display": "Ductal carcinoma in situ nuclear pleomorphism, grade 2: neither nuclear grade 1 nor nuclear grade 3 (finding)"
          },
          {
            "code": "369783007",
            "display": "Ductal carcinoma in situ nuclear pleomorphism, grade 3: Markedly pleomorphic nuclei, usually >2.5 red blood cells diameters, with coarse chromatin and multiple nucleoli (finding)"
          },
          {
            "code": "384741006",
            "display": "Grade cannot be determined (finding)"
          }
        ]
      }
    ]
  }
}